| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.057 | 0.09 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |